Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor
- PMID: 16830365
- PMCID: PMC4087364
- DOI: 10.3748/wjg.v12.i26.4161
Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor
Abstract
Aim: To investigate the clinicopathological features of gastrointestinal stromal tumor (GIST) and to study the reference indexes for malignancy.
Methods: Fifty-two cases of primary GIST were distinguished from a group of gastrointestinal mesenchymal tumors using a panel of antibodies such as CD117 and CD34 by immunohistochemical SP method. Their biological behaviors were analyzed using the expression of p21WAF1 and Bax in 52 cases of GIST.
Results: Grossly, the tumor size was between 1.5 cm and 13 cm (mean: 5.5 cm). Focal areas of hemorrhage, necrosis, or small cyst formation could be seen. Microscopically, the tumor was composed of spindle cells (20 cases), epithelioid cells (20 cases) and mixed cells (12 cases). Immunohistochemically, CD117 and CD34 showed diffuse strong positive expressions, the positive rates were 98.1% and 92.3%. SMA, S-100, NSE, NF and MBP showed focal positive expressions, the positive rates were 48.1%, 28.8%, 25%, 21.2% and 42.3% respectively. Vimentins were all positive desmin and CgA were all negative. In normal adult stomach and intestine, the immunoreactive staining for CD117 and CD34 showed immunoreactive interstitial cells of Cajal in myenteric neuroplexus. Among the 52 cases of GIST, 27 were positive for p21WAF1 (51.9%), 29 for Bax (55.8%). The expression of p21WAF1 and Bax had no significent difference with the localization, size, histological subtype of GIST, but had a significent difference with the histological grade (P = 0.000, respectively). p21WAF1 expression had a positive correlation to Bax expression (r = 0.461, P = 0.001, kappa = 0.459).
Conclusion: GIST has complicated arrangements and various cell types. Positivity of CD117 and CD34 is the most valuable factor in diagnosing GIST. Expression of p21WAF1 and Bax plays an important role in potential malignancy and malignancy rather than in benign GIST. p21WAF1 and Bax may be used as the markers in the assessment of GIST malignant potential.
Figures
Similar articles
-
[Gastrointestinal stromal tumor: a clinicopathological study of 74 cases].Zhonghua Bing Li Xue Za Zhi. 2005 Jan;34(1):6-10. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 15796874 Chinese.
-
[A clinicopathologic and immunohistochemical study on 76 cases of gastrointestinal stromal tumors].Zhonghua Bing Li Xue Za Zhi. 2002 Feb;31(1):20-5. Zhonghua Bing Li Xue Za Zhi. 2002. PMID: 11955330 Chinese.
-
[Expression of DOG-1 in gastrointestinal stromal tumor and its diagnostic application].Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):315-8. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21756825 Chinese.
-
[Clinicopathological and molecular features of the gastrointestinal stromal tumor].Gan To Kagaku Ryoho. 2011 May;38(5):715-21. Gan To Kagaku Ryoho. 2011. PMID: 21566429 Review. Japanese.
-
[Gastrointestinal stromal tumors. Diagnosis and estimating aggressiveness].Chirurg. 2008 Jul;79(7):625-9. doi: 10.1007/s00104-008-1525-7. Chirurg. 2008. PMID: 18496660 Review. German.
Cited by
-
Reactive nodular fibrous pseudotumor involving the gastrointestinal tract and mesentery: A case report and review of the literature.Oncol Lett. 2015 Mar;9(3):1343-1346. doi: 10.3892/ol.2015.2882. Epub 2015 Jan 16. Oncol Lett. 2015. PMID: 25663910 Free PMC article.
-
Clinicopathologic features and prognostic grouping of gastrointestinal stromal tumors (GISTs) in Pakistani patients: an institutional perspective.BMC Res Notes. 2018 Jul 11;11(1):457. doi: 10.1186/s13104-018-3562-8. BMC Res Notes. 2018. PMID: 29996918 Free PMC article.
-
Cyclin H expression is increased in GIST with very-high risk of malignancy.BMC Cancer. 2010 Jul 2;10:350. doi: 10.1186/1471-2407-10-350. BMC Cancer. 2010. PMID: 20598140 Free PMC article.
-
Simultaneous development of adenocarcinoma and gastrointestinal stromal tumor (GIST) in the stomach: case report.World J Surg Oncol. 2012 Jan 9;10:6. doi: 10.1186/1477-7819-10-6. World J Surg Oncol. 2012. PMID: 22230934 Free PMC article.
-
Gastrointestinal stromal tumors: key to diagnosis and choice of therapy.Mol Diagn Ther. 2008;12(3):131-43. doi: 10.1007/BF03256278. Mol Diagn Ther. 2008. PMID: 18510377 Review.
References
-
- Duensing A, Heinrich MC, Fletcher CD, Fletcher JA. Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer Invest. 2004;22:106–116. - PubMed
-
- Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM, Kim JS, Yook JH, Kim BS, Lee JS. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res. 2004;10:3076–3081. - PubMed
-
- Gelen T, Elpek GO, Aksoy NH, Ogüş M, Keleş N. p27 Labeling index and proliferation in gastrointestinal stromal tumors: correlations with clinicopathologic factors and recurrence. Jpn J Clin Oncol. 2003;33:346–352. - PubMed
-
- Haber MH, Gattuso P, Spitz DJ, David O. Differential diagnosis in surgical pathology. 1st ed. Beijing: Health Science Asia, Elsevier Science; 2002. pp. 188–192.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous